Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2. The new ...
Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts. Export articles to Mendeley Get article recommendations from ACS based on references in your ...
State Research Institute for Genetics and Selection of Industrial Microorganisms of National Research Center “Kurchatov Institute” (NRC “Kurchatov Institute”−GOSNIIGENETIKA), Moscow 117545, Russia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback